Recent News for RYTM - Rhythm Pharmaceuticals, Inc.

Date Title
Jun 25 The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
Jun 19 Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors
Jun 12 The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana
May 30 Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
May 22 Why Q3 Is Critical For Rhythm Pharmaceuticals
May 7 Here’s What Hedge Funds Think About Rhythm Pharmaceuticals, Inc. (RYTM)
May 7 Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference
May 3 Rhythm Pharmaceuticals misses by $0.08
May 3 Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
Apr 26 If You Had Bought Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock A Year Ago, You Could Pocket A 10% Gain Today
Apr 2 Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference
Mar 29 Seelos Therapeutics leads healthcare gainers; Vermillion and Chiasma among the losers
Mar 28 Rhythm Pharma's setmelanotide shows positive action in mid-stage obesity study
Mar 28 Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
Mar 8 Rhythm Pharmaceuticals misses by $0.16
Mar 8 Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 4 Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference
Feb 7 Recent Analysis Shows Alexion Pharmaceuticals, Plug Power, Rayonier Advanced Materials, SunCoke Energy, Rhythm Pharmaceuticals, and Armstrong Flooring Market Influences — Renewed Outlook, Key Drivers of Growth
Feb 1 Rhythm Pharmaceuticals: Opportunity To Take Position Ahead Of Pivotal Data
Jan 25 A Look At The Fair Value Of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Jan 14 Rhythm Pharma: Investible Based On Upcoming Trial Data
Jan 4 Rhythm Pharma up 6% ahead of corporate update at JPM19
Jan 4 Rhythm Pharmaceuticals to Outline Expected 2019 Milestones and Review Updated Clinical Data in Bardet-Biedl Syndrome at 37th Annual J.P. Morgan Healthcare Conference
Back to the Main RYTM Page...